[Synthesis and hemodynamic effects of the new inhibitor of endothelin converting enzyme].
Pozdnev
V F
VF
Gomazkov
O A
OA
Davydova
M P
MP
Medvedeva
N A
NA
D000818:Animals; D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors*; D001794:Blood Pressure / Q000187:drug effects; D004151:Dipeptides / Q000138:chemical synthesis / Q000494:pharmacology*; D019332:Endothelin-1 / Q000494:pharmacology; D000072396:Endothelin-Converting Enzymes; D006020:Glycopeptides / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D011480:Protease Inhibitors / Q000138:chemical synthesis / Q000494:pharmacology*; D011498:Protein Precursors / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013386:Succinates / Q000138:chemical synthesis / Q000494:pharmacology*
D004151:Dipeptides; D019332:Endothelin-1; D006020:Glycopeptides; C117200:PP 35; D011480:Protease Inhibitors; D011498:Protein Precursors; D013386:Succinates; D016282:Aspartic Acid Endopeptidases; D008666:Metalloendopeptidases; D000072396:Endothelin-Converting Enzymes; C008890:phosphoramidon